You have 9 free searches left this month | for more free features.

advanced papillary thyroid cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Surgical Management of Advanced Thyroid Cancer

Recruiting
  • Thyroid Carcinoma
  • +6 more
  • Thyroidectomy with or without lymphadenectomy or multivisceral resection
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 31, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

Not yet recruiting
  • Non-Medullary Thyroid Carcinoma
  • Digoxin tablet
  • (no location specified)
Aug 20, 2022

Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer Trial in Spain

Recruiting
  • Metastatic Thyroid Papillary Carcinoma
  • +2 more
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +14 more
Feb 18, 2022

Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

Recruiting
  • Solid Tumor
  • +6 more
  • CM-24 and Nivolumab - Dose Escalation
  • +4 more
  • Scottsdale, Arizona
  • +10 more
Jan 17, 2023

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

Terminated
  • Thyroid Cancer
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021

Papillary Thyroid Cancer and Central Lymp Node Dissection

Completed
  • Papillary Thyroid Cancer
    • Istanbul, Turkey
      BasaksehirCamSakuraSehirH
    May 15, 2023

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Papillary Thyroid Cancer Trial in Baltimore (Radiofrequency Ablation)

    Active, not recruiting
    • Papillary Thyroid Cancer
    • Radiofrequency Ablation
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Dec 5, 2022

    Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)

    Recruiting
    • Thyroid Cancer
    • +2 more
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Science
    Oct 13, 2023

    Galectin-3 in Papillary Thyroid Carcinoma

    Not yet recruiting
    • Galactin 3-thyroid Carcinoma
      • (no location specified)
      Jan 26, 2023

      Papillary Thyroid Carcinoma, Thermal Ablation Trial in Beijing (No Intervention)

      Recruiting
      • Papillary Thyroid Carcinoma
      • Thermal Ablation
      • No Intervention
      • Beijing, China
        Beijing Friendship Hospital
      Jul 19, 2023

      Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

      Recruiting
      • Papillary Thyroid Cancer
        • Milan, Italy
          Istituto Auxologico Italiano
        Mar 2, 2023

        Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)

        Recruiting
        • Thyroid Cancer
        • Recurrence
        • prophylactic central neck dissection
        • Beijing, Beijing, China
          Cancer Hospital, Chinese Academy of Medical Science
        Oct 8, 2023

        Tumor Deposits for Patients With Papillary Thyroid Carcinoma

        Completed
        • Exploring the Prognostic Value of Tumor Deposits PTC Patients
        • surgery
        • Guangzhou, Guangdong, China
          Nanfang Hospital, Southern Medical University
        Sep 18, 2023

        Association Between Primary Aldosteronism and Thyroid Cancer

        Completed
        • Thyroid Cancer, Papillary
        • Primary Aldosteronism
        • Secreening test for primary aldosteronism and Confirmatory Testing
        • São Paulo, Brazil
          Ana Alice Wolf Maciel
        Oct 3, 2023

        Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)

        Active, not recruiting
        • Thyroid Neoplasms
        • Brussels, Belgium
        • +21 more
        Oct 20, 2021

        A Gene Hunting Study for Familial Papillary Thyroid Cancer

        Recruiting
        • Thyroid
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Oct 13, 2022

          Papillary Thyroid Tumors by Mass-ARRAY

          Recruiting
          • Papillary Thyroid Cancer
          • Genotyping
          • Milan, MI, Italy
            Istituto Auxologico Italiano
          Mar 10, 2023

          Radioactive Iodine on the Immune System in Thyroid Cancer

          Not yet recruiting
          • Thyroid Carcinoma, Nonmedullary
          • Blood drawing
          • Nijmegen, Netherlands
            Radboud University Medical Center
          Aug 13, 2023

          Fascial Versus Standard Neck Dissection in N1b Papillary Thyroid

          Completed
          • Patients With Papillary Thyroid Cancer and N1b Status
          • Fascial Neck Dissection
          • Standard Neck Dissection
          • Rome, Italy
            Fondazione Policlinico Universitario Agostino Gemelli IRCCS
          Mar 27, 2023

          Cross-sectional Case and Control Study on Quality of Life,

          Recruiting
          • Papillary Thyroid Carcinoma
          • Thyroid Cancer
          • Thyroid lobectomy via trans-axillary approach
          • Thyroid lobectomy via open approach
          • Beijing, Beijing, China
            Department of General Surgery, Peking Union Medical College Hosp
          Jul 5, 2023

          Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

          Recruiting
          • Thyroid Cancer
          • +2 more
            • Taipei, Taiwan
              Chih-Yuan Wang, M.D
            Oct 16, 2022

            Concordance of Molecular Classification Based on Fine Needle

            Not yet recruiting
            • Papillary Thyroid Cancer
              • Calgary, Alberta, Canada
                Foothills Medical Centre
              Nov 17, 2023